Correlation Between Sana Biotechnology and Dermata Therapeutics
Can any of the company-specific risk be diversified away by investing in both Sana Biotechnology and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sana Biotechnology and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sana Biotechnology and Dermata Therapeutics, you can compare the effects of market volatilities on Sana Biotechnology and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sana Biotechnology with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sana Biotechnology and Dermata Therapeutics.
Diversification Opportunities for Sana Biotechnology and Dermata Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Sana and Dermata is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Sana Biotechnology and Dermata Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and Sana Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sana Biotechnology are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of Sana Biotechnology i.e., Sana Biotechnology and Dermata Therapeutics go up and down completely randomly.
Pair Corralation between Sana Biotechnology and Dermata Therapeutics
Given the investment horizon of 90 days Sana Biotechnology is expected to generate 0.99 times more return on investment than Dermata Therapeutics. However, Sana Biotechnology is 1.01 times less risky than Dermata Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Dermata Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 352.00 in Sana Biotechnology on December 8, 2024 and sell it today you would lose (94.00) from holding Sana Biotechnology or give up 26.7% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Sana Biotechnology vs. Dermata Therapeutics
Performance |
Timeline |
Sana Biotechnology |
Dermata Therapeutics |
Sana Biotechnology and Dermata Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sana Biotechnology and Dermata Therapeutics
The main advantage of trading using opposite Sana Biotechnology and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sana Biotechnology position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.Sana Biotechnology vs. Olema Pharmaceuticals | Sana Biotechnology vs. Cullinan Oncology LLC | Sana Biotechnology vs. Zentalis Pharmaceuticals Llc | Sana Biotechnology vs. X4 Pharmaceuticals |
Dermata Therapeutics vs. Zura Bio Limited | Dermata Therapeutics vs. Phio Pharmaceuticals Corp | Dermata Therapeutics vs. Sonnet Biotherapeutics Holdings | Dermata Therapeutics vs. 180 Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |